Back to today’s briefing

Story perspectives

Eli Lilly Launches Higher Doses of Zepbound for $499

6/16/2025

28 3

Summary

Story summary

Eli Lilly is set to launch higher doses of its weight-loss drug Zepbound, 12.5 mg and 15 mg, priced at $499 per month on its LillyDirect website, starting early August. Healthcare providers can begin prescribing these doses from July 7, a strategic effort to enhance access to obesity treatments in the face of limited insurance options.

1 of 1

Story summary

Eli Lilly is set to launch higher doses of its weight-loss drug Zepbound, 12.5 mg and 15 mg, priced at $499 per month on its LillyDirect website, starting early August. Healthcare providers can begin prescribing these doses from July 7, a strategic effort to enhance access to obesity treatments in the face of limited insurance options.